There has been increased interest in the clinical application of Class Ill (K+ channel blockers) as anti-arrhythmic agents. Unfortunately, reduction of the HERG current or other slow delayed rectifiers has been demonstrated to be proarrhythmic, both in abnormalities in coding genes or following pharmacologic intervention. This has placed renewed interest in the rapidly activating K+ currents that are important during the earlier phases of the cardiac action potential in various regions of the heart. However, K+ channel blockers vary in their selectivity for each K+ channel type, and display a variety of conformation specific interactions with K+ channels. Such conformation specific interactions can cause the degree of block of a channel to vary by orders of magnitude depending on the pattern of electrical stimulation. Such conformation dependent binding can be either detrimental or beneficial. This proposal focuses on examining the relationship between antiarrhythmic drug binding and a particular class of conformation changes, namely C-type inactivation in cardiac K+ channels. C-type inactivation is more widely distributed among cardiac K+channels than N-type and may be the dominant determinant of such important properties as recovery, K+sensitivity, pHo sensitivity and drug use-dependence. The goal of this proposal is to elucidate how C-type inactivation can influence the complex patterns of block and use-dependence seen with Class III agents in the cardiac channels, Kv1.4, Kvl.5 and Kv4.3. The main hypothesis of this proposal is that C-type inactivation involves a rearrangement of the intracellular pore resulting in its closure or partial closure. We further hypothesize that rotation of S6 is a critical event in this process and accounts for coupling of intracellular closure to the extracellular conformation changes in the S5-H5 linker region and the H5-S6linker. Our goal is to combine the structural information emerging from the new crystal structure with kinetic and biophysical measurements with computer modeling to achieve a detailed understanding of blocker-channel interactions. This study will investigate the intracellular and extracellular changes that occur during C-type inactivation and examine how these changes alter drug binding, accessibility and recovery. This study will provide a molecular basis for the use dependent properties of a broad class of cardiac ion channels and drugs that will further the development of safer and more effective anti-arrhythmic drug therapy.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Lathrop, David A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
State University of New York at Buffalo
Schools of Medicine
United States
Zip Code
Bett, Glenna C L; Kaplan, Aaron D; Rasmusson, Randall L (2016) Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes. Biophys J 110:284-6
Lin, Bo; Li, Yang; Han, Lu et al. (2015) Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy. Dis Model Mech 8:457-66
Rasmusson, Randall L; Anumonwo, Justus M (2015) Activation of HERG channels: opening new applications for the biophysics of antiarrhythmic therapy. Biophys J 108:1309-1311
Kim, Jong J; Yang, Lei; Lin, Bo et al. (2015) Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells. J Mol Cell Cardiol 81:81-93
Gold, Daniel A; Kaplan, Aaron D; Lis, Agnieszka et al. (2015) The Toxoplasma Dense Granule Proteins GRA17 and GRA23 Mediate the Movement of Small Molecules between the Host and the Parasitophorous Vacuole. Cell Host Microbe 17:642-52
Han, Lu; Li, Yang; Tchao, Jason et al. (2014) Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res 104:258-69
Parikh, Ashish; Patel, Divyang; McTiernan, Charles F et al. (2013) Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts. Circ Res 113:313-21
Bett, Glenna C L; Kaplan, Aaron D; Lis, Agnieszka et al. (2013) Electronic ""expression"" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm 10:1903-10
Zhou, Qinlian; Bett, Glenna C L; Rasmusson, Randall L (2012) Markov models of use-dependence and reverse use-dependence during the mouse cardiac action potential. PLoS One 7:e42295
Bett, Glenna Cl; Lis, Agnieszka; Wersinger, Scott R et al. (2012) A Mouse Model of Timothy Syndrome: a Complex Autistic Disorder Resulting from a Point Mutation in Cav1.2. N Am J Med Sci (Boston) 5:135-140

Showing the most recent 10 out of 21 publications